Literature DB >> 28497612

Accurate assessment of alpha-gal syndrome using cetuximab and bovine thyroglobulin-specific IgE.

Da Woon Sim1,2, Jong Sun Lee1, Kyung Hee Park1, Kyoung Yong Jeong1, Young-Min Ye3, Jae-Hyun Lee1, Jung-Won Park1.   

Abstract

SCOPE: IgE against galactose-α-1,3-galactose (α-Gal) causes alpha-gal syndrome. Bovine thyroglobulin (BTG) and cetuximab share this epitope. We aimed to determine the utility of specific IgE (sIgE) against cetuximab as compared to BTG for diagnosing alpha-gal syndrome. METHODS AND
RESULTS: Twelve patients with alpha-gal syndrome, 11 patients with immediate beef or pork allergy, 18 asymptomatic individuals with meat sensitization, and 10 non-atopic subjects were enrolled. We checked the levels of sIgE against BTG and cetuximab using the streptavidin CAP assay. Additionally, IgE reactivity to BTG and cetuximab was assessed by immunoblotting. All alpha-gal syndrome patients had a high concentration of sIgE against BTG, and cetuximab. In contrast to alpha-gal syndrome, patients with immediate allergic reactions to meat consumption and those with asymptomatic sensitization had significantly lower concentration of BTG and cetuximab sIgE, and a high prevalence of sIgE against bovine or porcine serum albumin. Although the concentration of sIgE against alpha-gal was lower in individuals with asymptomatic sensitization, IgE immunoblotting showed the presence of sIgE against α-Gal in this group.
CONCLUSION: Differentiation of alpha-gal syndrome from patients with immediate allergy to meat consumption or asymptomatic sensitization requires quantification of cetuximab- or BTG-induced sIgE via detection of IgE for α-gal.
© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Alpha-gal syndrome; Bovine thyroglobulin-specific IgE; Cetuximab-specific IgE; Component-resolved diagnosis; α-Gal

Mesh:

Substances:

Year:  2017        PMID: 28497612     DOI: 10.1002/mnfr.201601046

Source DB:  PubMed          Journal:  Mol Nutr Food Res        ISSN: 1613-4125            Impact factor:   5.914


  8 in total

Review 1.  Environmental and Molecular Drivers of the α-Gal Syndrome.

Authors:  Alejandro Cabezas-Cruz; Adnan Hodžić; Patricia Román-Carrasco; Lourdes Mateos-Hernández; Georg Gerhard Duscher; Deepak Kumar Sinha; Wolfgang Hemmer; Ines Swoboda; Agustín Estrada-Peña; José de la Fuente
Journal:  Front Immunol       Date:  2019-05-31       Impact factor: 7.561

2.  Tick Intrastadial Feeding and Its Role on IgE Production in the Murine Model of Alpha-gal Syndrome: The Tick "Transmission" Hypothesis.

Authors:  L Paulina Maldonado-Ruiz; Gunavanthi D Boorgula; Donghun Kim; Sherry D Fleming; Yoonseong Park
Journal:  Front Immunol       Date:  2022-03-04       Impact factor: 7.561

Review 3.  Transchromosomic bovines-derived broadly neutralizing antibodies as potent biotherapeutics to counter important emerging viral pathogens with a special focus on SARS-CoV-2, MERS-CoV, Ebola, Zika, HIV-1, and influenza A virus.

Authors:  AbdulRahman A Saied; Manuela Sales Lima Nascimento; Adriano Henrique do Nascimento Rangel; Krzysztof Skowron; Katarzyna Grudlewska-Buda; Kuldeep Dhama; Jaffer Shah; Ahmed Abdeen; Fouad S El-Mayet; Hassan Ahmed; Asmaa A Metwally
Journal:  J Med Virol       Date:  2022-06-11       Impact factor: 20.693

Review 4.  The Meat of the Matter: Understanding and Managing Alpha-Gal Syndrome.

Authors:  Jessica D Macdougall; Kevin O Thomas; Onyinye I Iweala
Journal:  Immunotargets Ther       Date:  2022-09-15

5.  A Case of Intraoperative Anaphylaxis Caused by Bovine-Derived Thrombin.

Authors:  Hye Jung Park; Kyung Soo Suk; Jung Won Park
Journal:  Allergy Asthma Immunol Res       Date:  2018-03       Impact factor: 5.764

6.  Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate.

Authors:  Thomas Luke; Richard S Bennett; Dawn M Gerhardt; Tracey Burdette; Elena Postnikova; Steven Mazur; Anna N Honko; Nicholas Oberlander; Russell Byrum; Dan Ragland; Marisa St Claire; Krisztina B Janosko; Gale Smith; Gregory Glenn; Jay Hooper; John Dye; Subhamoy Pal; Kimberly A Bishop-Lilly; Theron Hamilton; Kenneth Frey; Laura Bollinger; Jiro Wada; Hua Wu; Jin-An Jiao; Gene G Olinger; Bronwyn Gunn; Galit Alter; Surender Khurana; Lisa E Hensley; Eddie Sullivan; Peter B Jahrling
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

7.  Nationwide pharmacovigilance data for cetuximab-induced anaphylaxis and predictive model validation using prospective specific IgE detection.

Authors:  Kyung Hee Park; Jongsun Lee; Seung Hoon Beom; Sang Joon Shin; Joong Bae Ahn; Sung-Ryeol Kim; Jae-Hyun Lee; Jung-Won Park
Journal:  World Allergy Organ J       Date:  2021-06-23       Impact factor: 4.084

Review 8.  Tick Saliva and the Alpha-Gal Syndrome: Finding a Needle in a Haystack.

Authors:  Surendra Raj Sharma; Shahid Karim
Journal:  Front Cell Infect Microbiol       Date:  2021-07-20       Impact factor: 5.293

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.